Iconovo AB logo

Iconovo AB

We bring inhalation expertise to your business

39 employees · est. 2013 · Lund, Sweden

VS
PureIMS logo

PureIMS

🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug delivery

9 employees · est. 2014 · The Netherlands

Iconovo AB is the older company (2013 vs 2014); Iconovo AB is the larger of the two.

Side-by-Side Comparison

Iconovo AB PureIMS
Founded
2013 older 2014
Headquarters
Lund, Sweden The Netherlands
Employees
39 larger 9
Industry
Design, Medical Devices, Pharmaceutical Biotechnology, Life Sciences
Funding Stage
Grant Seed
Total Funding
$78.71M $40.00K
Funding Rounds
4 3
Services
Not tracked yet Development of Dry Powder Inhalers, Pharmaceutical Product Manufacturing, Drug Delivery System Innovation, Co-development with Pharma Partners
Target Customers
Not tracked yet Patients with Respiratory Conditions, Healthcare Providers, Pharmaceutical Companies, Medical Device Distributors
Taxonomy
Inhalation Expertise, Dry Powder Inhalers, Device Concepts, Reservoir Inhaler, Pre-metered Inhaler, Capsule-based Inhaler, Single-dose Disposable Inhaler, Formulation Development, Performance Testing, Documentation, Supply Chain, Licensing, Inhalation Products, Proprietary Technology, Pharmaceutical Devices Inhaled Drug Delivery, Dry Powder Inhaler Technology, Cyclops® Inhaler, Systemic Disease Treatment, Respiratory Disease Treatment, Parkinson's Disease Therapy, Cystic Fibrosis Treatment, Named Patient Program, Anaphylaxis Therapy, Strategic Licensing Partnerships, Pharmaceutical Commercialization, Clinical-stage Pharmaceuticals, Pharmaceutical Innovation, Inhalation Route For Drugs, Drug Development Leadership
Website
iconovo.se pureims.com
Iconovo AB logo

About Iconovo AB

Iconovo AB is a Swedish CDMO company that specializes in offering innovative and effective inhalation platforms to the international pharmaceutical industry. Founded in 2013, the company has established itself as a leader in the pharmaceutical sector. Iconovo boasts several types of patented dry pow...

PureIMS logo

About PureIMS

PureIMS is a promising clinical stage pharmaceutical company established in 2014 in The Netherlands. With a focus on innovative inhaled therapies utilizing its proprietary dry powder inhaler, Cyclops®, the company aims to address systemic and respiratory diseases with high unmet medical needs. Its c...

We will tell you when either one moves

BounceWatch watches Iconovo AB and PureIMS for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Iconovo AB and PureIMS — by email.

Frequently Asked Questions

Iconovo AB — We bring inhalation expertise to your business. PureIMS — 🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug delivery. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Iconovo AB has raised $78.71M while PureIMS has raised $40.00K.
Iconovo AB and PureIMS operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Iconovo AB with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Iconovo AB on 11 Sep 2024, and PureIMS on 13 Nov 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy